Neurology® Podcast

Dr. Margarita Fedorova talks with Dr. Pascal Geldsetzer about how the herpes zoster vaccination may have neuroprotective effects, potentially delaying or preventing dementia. 
Read the related article in The Lancet Neurology.
Disclosures can be found at Neurology.org.

Dr. Jason Crowell talks with Dr. John McDonough about the historical and economic factors shaping the US healthcare system and why understanding these systemic forces matters for neurologists and patient care. 
Read the related article in The Harvard Gazette. 
Disclosures can be found at Neurology.org.

Dr. Shuvro Roy talks with Dr. Daniel Daneshvar about the prevalence of CTE at death among NFL players and the association between CTE severity and the risk of dementia. 
Read the related article in the BMJ. 
Disclosures can be found at Neurology.org.

Dr. Kait Nevel talks with Dr. Katharina Schmidbauer about primary CNS T-cell lymphoma, highlighting diagnostic challenges, imaging characteristics, and treatment approaches for this rare disease. 
Read the related article in Neurology®. 
Disclosures can be found at Neurology.org.

The October Recall features four previously posted episodes on immune‑based therapies for neurologic disease. In the first episode, Dr. Bhaskar Roy reviews the latest treatments, comparing their efficacy and safety. The second episode, with Dr. Michael Levy, focuses on satralizumab for treating relapsing MOGAD, current management challenges, and the encouraging results of this new therapy. That conversation leads into an episode with Dr. Amanda L. Piquet, who discusses the efficacy and safety of miv-cel in patients with stiff person syndrome. The episode concludes with Dr. Irene Cortese highlighting recent advances in the treatment of PML. 
Podcast links: 
Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments
Safety and Efficacy of Satralizumab in Patients with Relapsing MOGAD
Miv-cel CD19 CAR T-Cell Therapy Shows Efficacy and Safety in Stiff Person Syndrome
Resolution of PML after Treatment with Virus-Specific T Cells and HCT
Article links:
Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments
Safety and Efficacy of Satralizumab in Patients with Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Miv-cel CD19 CAR T-Cell Therapy Shows Efficacy and Safety in Stiff Person Syndrome in a Pivotal, Multicenter, Phase 2 Study (KYSA-8)
Resolution of PML after Treatment with Virus-Specific T Cells and HCT
Disclosures can be found at Neurology.org.